Fluoride: Page 55

Xanodyne to withdraw propoxyphene from the U.S. market

By DrBicuspid.com staff writers

Xanodyne Pharmaceuticals, which makes Darvon and Darvocet -- the brand version of the prescription pain medication propoxyphene -- has agreed to withdraw the medication from the U.S. market after researchers found it can cause adverse heart conditions.

November 18, 2010

3rd Fosamax/ONJ trial begins in NY

By DrBicuspid.com staff writers

Another trial involving Fosamax and its alleged role in osteonecrosis of the jaw (ONJ) is now under way in New York, according to an article in the New York Times.

November 10, 2010

Study: Patients on bisphosphonates at low risk for ONJ

By Rabia Mughal

Occurrences of bisphosphonate-related osteonecrosis of the jaw (ONJ) may be rare in patients receiving once-a-year infusions of 5 mg of zoledronic acid, a new study in the Journal of the American Dental Association has found.

November 8, 2010

Recalls, lawsuit prompt ongoing propofol shortage

By Rob Goszkowski

For dental practitioners who regularly administer propofol, this past year has been a challenging one. A series of factors -- including recalls, shutdowns, and a multimillion dollar lawsuit -- rendered one of the most widely used anesthetics in medicine virtually unobtainable.

November 4, 2010

Bisphosphonates aid dental health in menopausal women

By Reuters Health

NEW YORK (Reuters Health) - In postmenopausal women with low bone mineral density, long-term bisphosphonate therapy appears to benefit the periodontium, researchers report in a September 10 online paper in Menopause.

October 20, 2010

FDA approves Botox to treat chronic migraine

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Botox injections (onabotulinumtoxinA) to prevent chronic migraine headaches in adult patients, the agency announced.

October 17, 2010

Osteoporosis drug rebuilds bone in patients with perio disease

By DrBicuspid.com staff writers

A drug marketed to grow bone in osteoporosis patients also works to heal bone wounds in patients with periodontal disease, a new study in the New England Journal of Medicine suggests.

October 17, 2010

Novartis wins 2nd ONJ/bisphosphonate trial

By DrBicuspid.com staff writers

A New Jersey jury ruled October 6 that Novartis provided adequate warnings about the risk of its bisphosphonate drugs, rejecting a lawsuit by a woman who claimed the drugs contributed to her development of osteonecrosis of the jaw (ONJ), according to a story by Bloomberg.

October 6, 2010

Preop prophylactic antibiotics -- yes or no?

By Rosemary Frei, MSc

Despite a recent meta-analysis indicating that giving patients antibiotics prior to implant surgery can prevent implant failures, some experts still question whether antibiotic prophylaxis is necessary in every case.

September 2, 2010

Did Univ. of Colo. dentists give patients too much midazolam?

By DrBicuspid.com staff writers

Dentists at the University of Colorado Denver School of Dental Medicine mistakenly injected as many as eight patients with potentially lethal doses of midazolam after the drug was erroneously added to the school's stock in 2008, according to a story by the Denver Post.

August 30, 2010

Can cancer patients benefit from phase I drug trials?

By Reuters Health

NEW YORK (Reuters Health), Aug 16 - Patients with advanced head and neck cancer survived just as well on experimental drugs in phase I trials as they did on FDA-approved standard therapies, a new report says.

August 15, 2010

U.S. Senate committee passes pay-for-delay limit

By DrBicuspid.com staff writers

A U.S. Senate committee on July 29 approved a provision meant to inhibit branded drug companies from delaying the introduction of generic versions of their drugs.

July 29, 2010

Previous Page

Page 55 of 61

Next Page